O-linked N-acetylglucosaminidase - Summit Therap
MK-8719 - Merck (MSD)
https://ash.confex.com/ash/2023/webprogram/Paper178962.html
 
Shinichiro Matsui, MD, PhD1,2; Chihiro Ri, MD3; Lyndsey C. Bolanos, MBA, BSc4; Kwangmin Choi, PhD4; Asuka Shibamiya, MD, PhD3; Arata Ishii, MD, PhD3; Koji Takaishi, MD, PhD3; Nagisa Oshima-Hasegawa, MD, PhD3; Shokichi Tsukamoto, MD, PhD3; Yusuke Takeda, MD, PhD3; Naoya Mimura, MD, PhD3,5; Koutaro Yokote, MD, PhD2; Daniel T. Starczynowski, PhD4,6,7; Emiko Sakaida, MD, PhD2,8; Tomoya Muto, MD, PhD3,9
 
Nov 3, 2023
 
Next